We are live on ! Find out more
FCMI

Foresite Capital Management IV Portfolio holdings

AUM $237M
1-Year Est. Return 107.53%
This Fund
S&P 500
This Quarter Est. Return
-23.69%
1 Year Est. Return
+107.53%
3 Year Est. Return
+149.4%
5 Year Est. Return
+13.8%
10 Year Est. Return
–
AUM
$486M
AUM Growth
-$193M
Cap. Flow
-$14.5M
Cap. Flow %
-2.98%
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
–
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OLMA icon
Olema Pharmaceuticals
OLMA
+$9.43M
2
TPST icon
Tempest Therapeutics
TPST
+$2.75M
3
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
+$2.29M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$171M 35.26%
9,671,643
– –
LYEL icon
2
Lyell Immunopharma
LYEL
$317M
$103M 21.15%
664,109
– –
ACRS icon
3
Aclaris Therapeutics
ACRS
$726M
$49.4M 10.17%
3,399,034
– –
PHVS icon
4
Pharvaris
PHVS
$2.28B
$46.9M 9.66%
3,261,926
– –
QSI icon
5
Quantum-Si Incorporated
QSI
$155M
$35.1M 7.23%
4,463,619
– –
NRIX icon
6
Nurix Therapeutics
NRIX
$2.41B
$34.9M 7.18%
1,205,798
– –
KURA icon
7
Kura Oncology
KURA
$800M
$25.9M 5.33%
1,849,947
– –
HLTH
8
DELISTED
Cue Health Inc. Common Stock
HLTH
$13.5M 2.78%
1,006,089
– –
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
$6.04M 1.24%
1,787,094
– –
OLMA icon
10
Olema Pharmaceuticals
OLMA
$1B
– –
-342,030
Closed -$9.43M
TPST icon
11
Tempest Therapeutics
TPST
$13.7M
– –
-14,632
Closed -$2.75M
DBTX
12
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
– –
-297,711
Closed -$2.29M

Similar funds

BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
AG
ASO Group Road Town $237M AUM
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
MFA
Millington Financial Advisors Naperville, Illinois $237M AUM 22.22% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
CB
CNB Bank Clearfield, Pennsylvania $238M AUM 26.55% 1-Year Est. Return

Foresite Capital Management IV's Q4 2021 Portfolio in Review

As of Q4 2021, Foresite Capital Management IV held 12 positions worth $486M, down 28% from $679M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management IV's Q4 2021 filing shows 3 closed positions. The largest sale was Olema Pharmaceuticals, an estimated $9.43M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management IV fully exited Olema Pharmaceuticals in Q4 2021, selling an estimated $9.43M.
  • Foresite Capital Management IV's ten largest holdings make up 100% of its $486M portfolio in Q4 2021.
  • Foresite Capital Management IV opened 0 new positions and closed 3 in Q4 2021.
  • Foresite Capital Management IV's portfolio value fell 28% quarter-over-quarter to $486M.

Based on Foresite Capital Management IV's 13F filing for Q4 2021, filed 11 Feb 2022.